The influence of the sympathetic outflow on aortic chemoreceptors of the cat during hypoxia and hypercapnia.
1. An attempt has been made to reconcile differing observations, made by different groups of investigators, on the responses of aortic chemoreceptors of cats during normoxia, hypoxia and hypercapnia. 2. In cats anaesthetized with sodium pentobarbitone it was observed that during hypoxic stimulation of twelve chemoreceptors, an intravenous injection of about 20 mg sodium pentobarbitone produced hypotension which was accompanied by an initial fall in chemoreceptor activity instead of the expected increase that invariably occurred in all the receptors when hypotension was produced mechanically by distending a balloon in the right atrium (twenty-six during normoxia, eleven during hypoxia and eight during hypercapnia). 3. In twelve receptors a reflex fall in blood pressure produced by injecting 8-25 micrograms veratridine (Bezold-Jarisch reflex) yielded results qualitatively similar to those following injection of sodium pentobarbitone. 4. In sixteen out of twenty-five chemoreceptors it was observed that ventilating the cat with 5.6-6.7% CO2 produced either no or little increase in activity; in nine receptors there was a clear increase in activity, which fell initially or was abolished after injecting a single dose of 20 mg sodium pentobarbitone. 5. In all seven chemoreceptors tested in seven deeply anaesthetized cats it was found that a larger dose (about 50-60 mg) of sodium pentobarbitone had no direct depressant effect on aortic chemoreceptor activity. It followed that the initial depressant effect of the much smaller doses of sodium pentobarbitone observed during hypoxic and hypercapnic stimulation (see above) must be due to reduction in the sympathetic outflow to the aortic bodies. This conclusion was supported by the results following injections of veratridine. 6. By comparing the present results with those reported previously it was concluded that the variations in the responses of aortic chemoreceptors during hypoxia and hypercapnia reported by different investigators could be partly due to variations in the level of sympathetic activity prevailing under different experimental conditions.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001011:Aorta / Q000294:innervation*; D001794:Blood Pressure; D002245:Carbon Dioxide / Q000502:physiology*; D002415:Cats; D002628:Chemoreceptor Cells / Q000502:physiology*; D009412:Nerve Fibers / Q000502:physiology; D010100:Oxygen / Q000502:physiology*; D010424:Pentobarbital / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000502:physiology*; D013997:Time Factors; D014701:Veratridine / Q000494:pharmacology
D002245:Carbon Dioxide; D014701:Veratridine; D010424:Pentobarbital; D010100:Oxygen